Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 3 (2006), Issue 3 (March)

1. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease.
   J Clin Invest, 116(3): 615-22. [Abstract] [Full-text]
2. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
   Ophthalmology, 113(3): 381-7. [Abstract] [Full-text]
3. Autosomal dominant polycystic kidney disease reduces the risk of diabetes mellitus.
   Arch Med Res, 37(3): 360-4. [Abstract] [Full-text]
4. Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz.:Fr. on glycemic responses in normal and diabetic rats.
   Life Sci, 78(17): 1957-66. [Abstract] [Full-text]
5. Comparison of presence and extent of coronary narrowing in patients with left bundle branch block without diabetes mellitus to patients with and without left bundle branch block but with diabetes mellitus.
   Am J Cardiol, 97(6): 857-9. [Abstract] [Full-text]
6. Effect of statin treatment on coronary collateral development in patients with diabetes mellitus.
   Am J Cardiol, 97(6): 772-4. [Abstract] [Full-text]
7. Activation of the Cbl insulin signaling pathway in cardiac muscle; dysregulation in obesity and diabetes.
   Biochem Biophys Res Commun, 342(3): 751-7. [Abstract] [Full-text]
8. Differential impairment of the sudomotor and nociceptor axon-reflex in diabetic peripheral neuropathy.
   Muscle Nerve, 33(4): 494-9. [Abstract] [Full-text]
9. Advancing the science of perceptual accuracy in pediatric asthma and diabetes.
   J Pediatr Psychol, 31(3): 233-45. [Abstract] [Full-text]
10. Role of the JAK/STAT signaling pathway in diabetic nephropathy.
    Am J Physiol Renal Physiol, 290(4): F762-8. [Abstract] [Full-text]
11. Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.
    Am J Physiol Renal Physiol, 290(4): F828-37. [Abstract] [Full-text]
12. SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice.
    Am J Physiol Renal Physiol, 290(4): F813-20. [Abstract] [Full-text]
13. Type 1 diabetes.
    Lancet, 367(9513): 847-58. [Abstract] [Full-text]
14. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis.
    Gastroenterology, 130(3): 759-70. [Abstract] [Full-text]
15. Genetic analysis of the diabetes-prone C57BLKS/J mouse strain reveals genetic contribution from multiple strains.
    Biochim Biophys Acta, 1762(4): 440-6. [Abstract] [Full-text]
16. Agreement of the Heidelberg Retina Tomograph II macula edema module with fundus biomicroscopy in diabetic maculopathy.
    Arch Ophthalmol, 124(3): 337-42. [Abstract] [Full-text]
17. Health benefits of physical activity: the evidence.
    CMAJ, 174(6): 801-9. [Abstract] [Full-text]
18. A prospective study of pregravid physical activity and sedentary behaviors in relation to the risk for gestational diabetes mellitus.
    Arch Intern Med, 166(5): 543-8. [Abstract] [Full-text]
19. An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8.
    Arch Intern Med, 166(5): 507-13. [Abstract] [Full-text]
20. Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications.
    Circulation, 113(10): 1353-60. [Abstract] [Full-text]
21. Meticillin-resistant Staphylococcus aureus infection in diabetic mice enhanced inflammation and coagulation.
    J Med Microbiol, 55: 379-85. [Abstract] [Full-text]
22. Critical role of cholic acid for development of hypercholesterolemia and gallstones in diabetic mice.
    Biochem Biophys Res Commun, 342(4): 1382-8. [Abstract] [Full-text]
23. Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin.
    Biochem Biophys Res Commun, 342(4): 1174-7. [Abstract] [Full-text]
24. The mass, but not the frequency, of insulin secretory bursts in isolated human islets is entrained by oscillatory glucose exposure.
    Am J Physiol Endocrinol Metab, 290(4): E750-6. [Abstract] [Full-text]
25. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis.
    JAMA, 295(11): 1288-99. [Abstract] [Full-text]
26. Selective deletion of Pten in pancreatic beta cells leads to increased islet mass and resistance to STZ-induced diabetes.
    Mol Cell Biol, 26(7): 2772-81. [Abstract] [Full-text]
27. Synergistic targeting with bone marrow-derived cells and PDGF improves diabetic vascular function.
    Am J Physiol Heart Circ Physiol, 290(4): H1387-92. [Abstract] [Full-text]
28. Reduced Ca2+-dependent activation of large-conductance Ca2+-activated K+ channels from arteries of Type 2 diabetic Zucker diabetic fatty rats.
    Am J Physiol Heart Circ Physiol, 290(4): H1520-7. [Abstract] [Full-text]
29. Impaired potency of bone marrow mononuclear cells for inducing therapeutic angiogenesis in obese diabetic rats.
    Am J Physiol Heart Circ Physiol, 290(4): H1362-9. [Abstract] [Full-text]
30. Repaglinide in the management of new-onset diabetes mellitus after renal transplantation.
    Am J Transplant, 6(4): 842-6. [Abstract] [Full-text]
31. Prolonged survival of allogeneic islets in cynomolgus monkeys after short-term anti-CD154-based therapy: nonimmunologic graft failure?
    Am J Transplant, 6(4): 687-96. [Abstract] [Full-text]
32. Diabetic cardiomyopathy: the search for a unifying hypothesis.
    Circ Res, 98(5): 596-605. [Abstract] [Full-text]
33. Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury.
    Circ Res, 98(5): 697-704. [Abstract] [Full-text]
34. Effects of insulin treatment without and with recurrent hypoglycemia on hypoglycemic counterregulation and adrenal catecholamine-synthesizing enzymes in diabetic rats.
    Endocrinology, 147(4): 1860-70. [Abstract] [Full-text]
35. Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity.
    Toxicol Appl Pharmacol, 211(3): 221-32. [Abstract] [Full-text]
36. Should the lower limit of impaired fasting glucose be reduced from 110 mg/dL in Korea?
    Metabolism, 55(4): 489-93. [Abstract] [Full-text]
37. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus.
    Metabolism, 55(4): 461-6. [Abstract] [Full-text]
38. The utility of fasting glucose for detection of prediabetes.
    Metabolism, 55(4): 434-8. [Abstract] [Full-text]
39. Internal arteriovenous fistula within a radial forearm flap--a novel technique to increase femorodistal bypass graft flow to the diabetic foot and flap covering ischaemic tissue loss.
    Eur J Vasc Endovasc Surg, 31(4): 423-30. [Abstract] [Full-text]
40. Children as partners with adults in their medical care.
    Arch Dis Child, 91(4): 300-3. [Abstract] [Full-text]
41. Microarray analysis of thioacetamide-treated type 1 diabetic rats.
    Toxicol Appl Pharmacol, 212(1): 69-78. [Abstract] [Full-text]
42. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Science, 311(5768): 1778-80. [Abstract] [Full-text]
43. Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution.
    Science, 311(5768): 1775-8. [Abstract] [Full-text]
44. Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration.
    Science, 311(5768): 1774-5. [Abstract] [Full-text]
45. Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy.
    Hypertension, 47(4): 699-705. [Abstract] [Full-text]
46. Prolonged ischemic conduction failure after reperfusion in diabetic nerve.
    Muscle Nerve, 33(3): 350-5. [Abstract] [Full-text]
47. Implications of new geriatric diabetes care guidelines for the assessment of quality of care in older patients.
    Med Care, 44(4): 373-7. [Abstract] [Full-text]
48. Early supernormal retinal oxygenation response in patients with diabetes.
    Invest Ophthalmol Vis Sci, 47(4): 1612-9. [Abstract] [Full-text]
49. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy.
    Invest Ophthalmol Vis Sci, 47(4): 1594-9. [Abstract] [Full-text]
50. Prevention of loss of renal function over time in patients with diabetic nephropathy.
    Am J Med, 119(5): S40-7. [Abstract] [Full-text]
51. New treatment strategies for patients with hypertension and insulin resistance.
    Am J Med, 119(5): S24-30. [Abstract] [Full-text]
52. The obese patient with diabetes mellitus: from research targets to treatment options.
    Am J Med, 119(5): S17-23. [Abstract] [Full-text]
53. Etiology of insulin resistance.
    Am J Med, 119(5): S10-6. [Abstract] [Full-text]
54. Association of hemoglobin A(1c) level with the severity of coronary artery disease in patients with diabetes mellitus.
    Am J Cardiol, 97(7): 968-9. [Abstract] [Full-text]
55. Molecular variants and derivatives of insulin for improved glycemic control in diabetes.
    Prog Biophys Mol Biol, 91(3): 199-228. [Abstract] [Full-text]
56. Use of a blood glucose monitoring manual to enhance monitoring adherence in adults with diabetes: a randomized controlled trial.
    Arch Intern Med, 166(6): 689-95. [Abstract] [Full-text]
57. Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index.
    Arch Intern Med, 166(6): 682-8. [Abstract] [Full-text]
58. Effect of quality improvement on racial disparities in diabetes care.
    Arch Intern Med, 166(6): 675-81. [Abstract] [Full-text]
59. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Circulation, 113(12): 1588-96. [Abstract] [Full-text]
60. Glycogen synthase kinase 3beta together with 14-3-3 protein regulates diabetic cardiomyopathy: effect of losartan and tempol.
    FEBS Lett, 580(8): 1932-40. [Abstract] [Full-text]
61. Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist.
    Am Heart J, 151(4): 798.e9-15. [Abstract] [Full-text]
62. Pharmacokinetics of oltipraz in rat models of diabetes mellitus induced by alloxan or streptozotocin.
    Life Sci, 78(20): 2287-94. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.